BioStock: Oncology Venture advancing in all priority programs

Treatment outcomes in cancer care could be significantly improved if there was a way to identify whether or not each individual patient was likely to respond to a specific treatment. Danish biotech Oncology Venture has developed a platform technology to enable such predictions through drug-specific companion diagnostics. BioStock has delved into the major events for the company, post management reform.

Läs hela artikeln på biostock.se:

https://www.biostock.se/2019/12/oncology-venture-advancing-in-all-priority-programs/

Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital. https://www.biostock.se